BIOA
BIOA
NASDAQ · Pharmaceuticals

Bioage Labs Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks
$5.34
-0.20 (-3.61%)
As of Nov 8, 10:22 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 12 80%
Hold 3 20%
Sell 0 0%
Price Target
Analyst Price Target +146.1% upside
Low Target $9.99
Average Target $13.14
High Target $19.07
Current Price $5.34
Current
$5.34
Target
$13.14
$9.99 $13.14 avg $19.07
Scenario Analysis
Bear Case
$9.99
87.1%
Low target
Base Case
$13.14
+146.1%
Avg target
Bull Case
$19.07
+257.1%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$25.96
-79.4% from high
52-Week Low
$4.81
+11.0% from low
Target vs 52W High
$13.14
-49.4% vs high
Next Earnings Report
Nov 25, 2026
15d
until earnings
EPS Est: $-0.64
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
 Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
 Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
 Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
 Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
 Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
 Hold 22 41% $209.87 +164.3%